Max S Wicha Selected Research

Max S Wicha Research Topics

Disease

96	Neoplasms (Cancer) 11/2023 - 04/2003
64	Breast Neoplasms (Breast Cancer) 11/2023 - 07/2004
28	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2010
11	Triple Negative Breast Neoplasms 12/2022 - 01/2015
9	Carcinogenesis 01/2021 - 01/2009
8	Squamous Cell Carcinoma of Head and Neck 08/2021 - 09/2010
5	Melanoma (Melanoma, Malignant) 11/2022 - 01/2014
5	Circulating Neoplastic Cells 12/2020 - 12/2014
4	Hypoxia (Hypoxemia) 01/2020 - 02/2012
3	Disease Progression 01/2022 - 01/2019
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 01/2016
3	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 06/2011
2	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 03/2015
2	Inflammation (Inflammations) 01/2019 - 10/2011
2	Mucoepidermoid Carcinoma 01/2019 - 09/2015
2	Lung Neoplasms (Lung Cancer) 01/2017 - 10/2013
2	Prostatic Neoplasms (Prostate Cancer) 02/2013 - 05/2012
1	Residual Neoplasm 08/2022
1	Infections 11/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021
1	Colitis 11/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020

Drug/Important Bio-Agent (IBA)

17	Aldehyde DehydrogenaseIBA 01/2023 - 11/2007
10	VaccinesIBA 08/2022 - 04/2012
9	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2011
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 08/2010
8	Phenobarbital (Luminal)FDA Link 01/2019 - 01/2009
7	CytokinesIBA 01/2019 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2007
6	Estrogen ReceptorsIBA 10/2023 - 07/2004
6	RNA (Ribonucleic Acid)IBA 08/2023 - 01/2018
6	AntigensIBA 11/2022 - 04/2012
6	Trastuzumab (Herceptin)FDA Link 08/2016 - 08/2012
5	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2012
4	Transcription Factors (Transcription Factor)IBA 11/2022 - 01/2005
4	Biocompatible Materials (Biomaterials)IBA 01/2021 - 01/2019
4	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2013
4	CurcuminIBA 01/2016 - 08/2010
3	LigandsIBA 01/2022 - 04/2013
3	Estrogens (Estrogen)FDA Link 01/2022 - 04/2016
3	graphene oxideIBA 01/2019 - 10/2013
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2018 - 04/2013
3	sulforaphaneIBA 01/2017 - 05/2010
3	Angiogenesis InhibitorsIBA 04/2015 - 02/2012
3	Interleukin-8 (Interleukin 8)IBA 10/2011 - 02/2009
2	Peptides (Polypeptides)IBA 11/2022 - 08/2022
2	reparixinIBA 11/2021 - 02/2010
2	Immune Checkpoint InhibitorsIBA 11/2021 - 10/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 01/2017
2	IntegrinsIBA 08/2021 - 01/2020
2	AdipokinesIBA 01/2019 - 12/2015
2	3- (4- ((4- chlorophenyl)sulfonyl)- 4- (2,5- difluorophenyl)cyclohexyl)propanoic acidIBA 01/2018 - 03/2013
2	tocilizumab (atlizumab)FDA Link 01/2018 - 11/2014
2	AntibodiesIBA 11/2017 - 01/2016
2	ChemokinesIBA 09/2017 - 01/2015
2	Phosphotransferases (Kinase)IBA 08/2017 - 09/2013
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017 - 01/2009
2	Docetaxel (Taxotere)FDA Link 01/2017 - 03/2013
2	integrin-linked kinaseIBA 04/2016 - 06/2015
2	SuspensionsIBA 01/2016 - 01/2005
2	Bevacizumab (Avastin)FDA Link 04/2015 - 02/2012
2	InterleukinsIBA 11/2014 - 10/2011
2	AndrogensIBA 02/2013 - 05/2012
2	piperineIBA 09/2011 - 08/2010
2	Aldehyde Dehydrogenase 1 FamilyIBA 08/2011 - 04/2009
2	TensinsIBA 06/2009 - 01/2007
1	Doxycycline (Periostat)FDA LinkGeneric 01/2023
1	Long Noncoding RNAIBA 01/2023
1	Conditioned Culture MediaIBA 12/2022
1	IronIBA 01/2022
1	Fulvestrant (Faslodex)FDA Link 01/2022
1	OTX015IBA 01/2022
1	abemaciclibIBA 01/2022
1	Succinic Acid (Succinate)IBA 11/2021
1	Cell-Free Nucleic AcidsIBA 12/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2020
1	NanovaccinesIBA 10/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Rimantadine FDA LinkGeneric 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 11/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Fish OilsIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	MI-773IBA 01/2019
1	proteinase InIBA 10/2018

Therapy/Procedure

43	Therapeutics 11/2023 - 04/2003
13	Drug Therapy (Chemotherapy) 01/2023 - 06/2008
10	Immunotherapy 08/2022 - 04/2012
4	Radiotherapy 08/2021 - 10/2010
4	Lab-On-A-Chip Devices 12/2019 - 12/2014
3	Replantation 04/2015 - 05/2010
2	Investigational Therapies (Experimental Therapy) 10/2016 - 03/2013
2	Chemoprevention 09/2011 - 05/2010
2	Aftercare (After-Treatment) 08/2011 - 06/2011
1	Immunomodulation 01/2021
1	Role Playing (Playing, Role) 01/2019